Mandate

Vinge has advised Lantmännen in connection with the divestment of Lantmännen Agrovärme

Vinge has advised Lantmännen in connection with the divestment of Lantmännen Agrovärme to Solör Bioenergi.

Lantmännen Agrovärme produces, distributes, and sells district heating from 19 plants in the southern and central parts of Sweden to approximately 1100 customers. Lantmännen Agrovärme's strategy is to contribute to a circular economy. About 95 percent of the heat from Lantmännen Agrovärme comes from the combustion of locally produced biofuels, such as wood chips, energy forests, wood pellets and rest products from agriculture.

Vinges team consisted primarily of Christina Kokko, Peter Sundgren, Ellinor Wargenbrant and Elsie Nassar (M&A), Eva Fredriksson (Commercial Agreements), Sara Strandberg (Employment) and Julia Hagelberg (Project assistant).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026